Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
Alkem Laboratories IPO is a book build issue of ₹1,347.76 crores. The issue is entirely an offer for sale of 1.29 crore shares of ₹1,347.76 crore.
Alkem Laboratories IPO bidding started from Dec 8, 2015 and ended on Dec 10, 2015. The shares got listed on BSE, NSE on Dec 23, 2015.
Alkem Laboratories IPO price band is set at ₹1050.00 per share . The lot size for an application is 14. The minimum amount of investment required by an retail is ₹14,280 (14 shares). The lot size investment for sNII is 14 lots (196 shares), amounting to ₹2,05,800, and for bNII, it is 69 lots (966 shares), amounting to ₹10,14,300.
The issue includes a reservation of up to 2,98,913 shares for employees offered at a discount of ₹100.00 to the issue price.
Axis Capital Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue.
Refer to Alkem Laboratories IPO RHP for detailed Information.
| IPO Date | December 8, 2015 to December 10, 2015 |
| Listing Date | December 23, 2015 |
| Face Value | ₹2 per share |
| Issue Price Band | ₹1020 to ₹1050 per share |
| Issue Price Final | ₹1050 per share |
| Lot Size | 14 Shares |
| Sale Type | Offer For Sale |
| Total Issue Size | 1,28,53,442 shares (aggregating up to ₹1,347.76 Cr) |
| Employee Discount | ₹100.00 |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 11,95,65,000 shares |
| Share Holding Post Issue | 11,95,65,000 shares |
Alkem Laboratories IPO offers total 1,28,53,442 shares. Out of which 62,77,264 (48.84%) allocated to QIB, 25,10,906 (19.53%) allocated to QIB, 18,83,179 (14.65%) allocated to NII, 43,94,086 (34.19%) allocated to RII and 37,66,358 (29.30%) allocated to Anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| QIB Shares Offered | 62,77,264 (48.84%) | NA |
| − Anchor Investor Shares Offered | 37,66,358 (29.30%) | NA |
| − QIB (Ex. Anchor) Shares Offered | 25,10,906 (19.53%) | NA |
| NII (HNI) Shares Offered | 18,83,179 (14.65%) | NA |
| Retail Shares Offered | 43,94,086 (34.19%) | 3,13,863 |
| Employee Shares Offered | 2,98,913 (2.33%) | NA |
| Total Shares Offered | 1,28,53,442 (100.00%) |
| Application Category | Maximum Bidding Limits | Bidding at Cut-off Price Allowed |
|---|---|---|
| Only RII | Up to Rs 2 Lakhs | Yes |
| Only sNII | Rs 2 Lakhs to Rs 10 Lakhs | No |
| Only bNII | Rs 10 Lakhs to NII Reservation Portion | No |
| Only employee | Yes | |
| Employee + RII/NII |
|
Yes for Employee and RII/NII |
Alkem Laboratories IPO opens on December 8, 2015, and closes on December 10, 2015.
| IPO Open Date | Tue, Dec 8, 2015 |
| IPO Close Date | Thu, Dec 10, 2015 |
| Tentative Listing Date | Wed, Dec 23, 2015 |
| Cut-off time for UPI mandate confirmation | 5 PM on Thu, Dec 10, 2015 |
Investors can bid for a minimum of 14 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 14 | ₹14,700 |
| Retail (Max) | 13 | 182 | ₹1,91,100 |
| S-HNI (Min) | 14 | 196 | ₹2,05,800 |
| S-HNI (Max) | 68 | 952 | ₹9,99,600 |
| B-HNI (Min) | 69 | 966 | ₹10,14,300 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in 1973, Alkem Labs is leading India based pharmaceutical company engaged in the development, manufacture and sale of pharmaceutical and neutraceutical products.
Alkem Labs produces branded generics, generic drugs, active pharmaceutical ingredients and neutraceuticals, which they market in India and 55 countries internationally, primarily the United States.
Company's pharmaceutical business is organized into domestic and international operations. Alkem Labs has a portfolio of over 736 brands in India. Company's most significant therapeutic areas in domestic market are anti-infectives, gastro-intestinal, pain and analgesics, and vitamins, minerals and nutrients.
Alkem Labs have a total of 16 manufacturing facilities: 14 manufacturing facilities at five locations in India and two in the United States. Company have four research and development facilities, two in India and two in the United States. As of June 30, 2015, company employed 483 scientists in research and development functions.
Highlights:
1. Alkem Labs is 5th largest pharmaceutical company in India in terms of domestic sales.
2. Alkem Labs products are also sold in 56 countries. In the United States, company has filed 66 abbreviated new drug applications.
3. Company sells a range of high-quality, cost effective generic drugs to major drug chains, pharmaceutical retailers, wholesalers, food and grocery stores, distributors and managed care companies in the United States.
| Particulars | For the year/period ended (in Rs. Million) | |||
| 31 Mar 15 | 31 Mar 14 | 31 Mar 13 | 31 Mar 12 | |
| Total Income | 33,595.20 | 28,395.80 | 24,690.10 | 20,640.10 |
| Profit After Tax (PAT) | 4,370.90 | 4,402.00 | 4,667.80 | 4,318.10 |
| KPI | Values |
|---|---|
| RoNW | 15.4% |
The objects of the Offer are:
1. To achieve the benefits of listing the Equity Shares on the Stock Exchanges and
2. For the sale of 12,853,442 Equity Shares by the Selling Shareholders.
[Dilip Davda] <p>Considering company's position, popular brands in the pharma sector and the given track records with over 22% CAGR in revenue growth for last five fiscals and over 36% growth in first half of current fiscal, reasonable pricing, <span style="text-decoration: underline;"><strong>it's a worthy bet for short to long term.</strong> </span></p> Read detail review...
| Listing Date | December 23, 2015 |
| BSE Script Code | 539523 |
| NSE Symbol | ALKEM |
| ISIN | INE540L01014 |
| Final Issue Price | ₹1050 per share |
| BSE Listing Group | B |
Alkem Laboratories Ltd.
Alkem House,
Senapati Bapat Marg,
Lower Parel, Mumbai 400 013
Mumbai, Maharashtra
Phone: +91 22 3982 9999
Email: investors@alkem.com
Website: http://www.alkemlabs.com/
MUFG Intime India Pvt.Ltd.
Phone: +91-22-4918 6270
Email: all.ipo@linkintime.co.in
Website: https://linkintime.co.in/Initial_Offer/public-issues.html
Alkem Laboratories IPO is a main-board IPO of 1,28,53,442 equity shares of the face value of ₹2 aggregating up to ₹1,347.76 Crores. The issue is priced at ₹1050 per share. The minimum order quantity is 14.
The IPO opens on December 8, 2015, and closes on December 10, 2015.
MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Alkem Laboratories IPO using UPI as a payment gateway. Zerodha customers can apply in Alkem Laboratories IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Alkem Laboratories IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Alkem Laboratories IPO opens on December 8, 2015 and closes on December 10, 2015.
Alkem Laboratories IPO lot size is 14, and the minimum amount required for application is ₹14,700.
You can apply in Alkem Laboratories IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Alkem Laboratories IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Alkem Laboratories IPO allotment status.
The Alkem Laboratories IPO listing date is on Wednesday, December 23, 2015.
Useful Articles
RHP